I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Activity and Safety of Peptide-based Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and Neck.
The purpose of this project is to realize a randomized open-label study (EudraCT number: 2020-000120-19) to evaluate the safety and the anti-tumor activity of peptide(s)-based immunotherapy in an umbrella window pre-operative opportunity phase II study in patients with squamous cell carcinoma of the head and neck.
second malignancy
metastasis
squamous cell carcinoma of the head and neck
measurable disease
platelet count
- 0 views
- 19 Feb, 2024